Articles From: Actions Semiconductor Revises Revenue Outlook for the Second Quarter of 2014 to The Howard Hughes Corporation® Announces Smith’s Food & Drug® as an Anchor for Cottonwood Redevelopment

ZHUHAI, China , July 8, 2014 /PRNewswire/ -- Actions Semiconductor Co., Ltd.
Sign-up for Actions Semiconductor Revises Revenue Outlook for the Second Quarter of 2014 investment picks VANCOUVER, BC--(Marketwired - July 08, 2014) - Balmoral Resources Ltd.
Sign-up for Balmoral Resumes Drilling of Martiniere Gold System, Detour Gold Trend Project, Quebec investment picks
ROCKVILLE, Md., July 8, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN) , today announced the execution of a royalty acquisition agreement ("Agreement") with HealthCare Royalty Partners ("HC Royalty"). Per the Agreement, HC Royalty will make a $30 million cash payment to Supernus in consideration for acquiring from Supernus certain royalty and milestone rights related to the commercialization of Orenitram™ (treprostinil) Extended-Release Tablets by Supernus' partner United Therapeutics Corporation.
Sign-up for Supernus to Receive $30 Million in Non-Dilutive Royalty Deal investment picks
HOUSTON , July 8, 2014 /PRNewswire/ -- PetroLogistics LP (NYSE: PDH) ("PetroLogistics") announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with the previously announced acquisition of PetroLogistics by Flint Hills Resources, LLC ("Flint Hills") expired at 11:59 P.M. (Eastern Time) on July 7 , 2014.
Sign-up for PetroLogistics LP Announces Expiration Of Hart-Scott-Rodino Waiting Period For Merger With Flint Hills Resources investment picks LONDON, UNITED KINGDOM --
Sign-up for European Commission selects CGI to support the Galileo program's Commercial Service initiative investment picks
CHICAGO , July 8, 2014 /PRNewswire/ -- Bankers Life and Casualty Company , a national life and health insurer, recently won three 2014 Communicator Awards of Distinction for its suite of mobile applications.
Sign-up for Bankers Life and Casualty Company Honored with Three Communicator Awards of Distinction for Mobile Application Suite investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- The pound fell against the U.S. dollar Tuesday, pulled lower after a decline in U.K. manufacturing output, an unexpected result since a recent run of data have shown strengthening in the economy.
Sign-up for Pound pinched after surprise U.K.-factory data fall investment picks
UTI campuses in Illinois and North Carolina are among only 22 ACCSC-accredited institutions to receive the prestigious School of Excellence Award SCOTTSDALE, Ariz.
Sign-up for Universal Technical Institute Named School of Excellence, Highest Institutional Achievement Award by Accrediting Commission of Career Schools and Colleges investment picks
By Tomi Kilgore Alcoa may no longer be a "blue chip" stock since its ouster from the Dow Jones Industrial Average, but it is still viewed as the company that will ceremoniously kick-off earnings season when it reports second-quarter results after Tuesday's close.
Sign-up for UPDATE: Alcoa earnings: Aerospace demand, aluminum pricing to be in focus investment picks
RANCHO CORDOVA, Calif., July 8, 2014 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL) , an autologous cell-based regenerative medicine company, announced today that it recently participated in a pre-submission IDE (Investigational Device Exemption) teleconference with the Food and Drug Administration's ("FDA") Center for Biologics Evaluation and Research to discuss the Company's proposed pivotal clinical trial design for the treatment of Critical Limb Ischemia ("CLI") using its CLIRST (Critical Limb Ischemia Rapid Stem cell Therapy) treatment protocol delivered via the Company's proprietary SURGWERKS-CLI kit.
Sign-up for CESCA Management Provides Regulatory Update on Its Proposed U.S. Pivotal Critical Limb Ischemia Clinical Trial investment picks
Customers who order using Domino's iPad® app could win free pizza for a year ANN ARBOR, Mich.
Sign-up for Domino's Pizza® Launches Sweepstakes in Celebration of New iPad® Ordering App investment picks
NEW YORK (MarketWatch) -- KLA-Tencor (KLAC) said it increased its stock buyback program by up to 13 million additional shares.
Sign-up for KLA-Tencor increases stock buyback, dividend investment picks
Accenture (NYSE: ACN) has introduced a new release of Accenture Duck Creek Policy designed to help property and casualty insurers streamline policy administration processes, more clearly define workflows and get products to market more quickly.
Sign-up for Accenture Introduces New Release of Duck Creek Policy Software for Property & Casualty Insurance Companies investment picks
Gabelli & Company will host its 20 th Annual Aircraft Supplier Conference on September 9 in New York City.
Sign-up for Gabelli & Company’s 20th Annual Aircraft Supplier Conference investment picks CHICAGO, IL --
Sign-up for Cobra Electronics Introduces Cobra AirWave Box; A Bluetooth-Enabled, Portable, Waterproof Audio Speaker investment picks PLEASANTON, CA --
Sign-up for Mobinil Selects CallidusCloud's Commissions to Optimize Dealer Compensation investment picks
- Nearly 4 in 10 (38%) people surveyed are planning an overnight road trip this summer - 8 in 10 (81%) respondents plan to spend the same amount of money or more than last year - Over 3 in 4 (77%) consumers surveyed indulge in food or drinks they would not normally purchase but enjoy while on vacation AUSTIN, Texas , July 8, 2014 /PRNewswire/ -- Are road trips the most economical summer vacation option?
Sign-up for Are We on the Road to a Blown Budget? A Majority of Americans Think People End Up Spending More Than Expected During Road Trips investment picks
Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today announced that it has been awarded several contracts by Spirit AeroSystems, Inc. (NYSE:SPR) to produce structural assemblies for the Boeing 737 MAX commercial jetliner.
Sign-up for Spirit Selects Ducommun for Boeing 737 MAX investment picks
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its wearable technology for treatment of chronic pain received 510(k) clearance (K140333) from the U.S. Food and Drug Administration (FDA) for over-the-counter use.
Sign-up for FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic Pain investment picks
Moody’s Corporation (NYSE:MCO) (“Moody’s” or the “Company”) today announced that it priced an underwritten public offering of $450 million aggregate principal amount of 2.75% senior unsecured notes due 2019, and $300 million aggregate principal amount of 5.25% senior unsecured notes due 2044.
Sign-up for Moody's Corporation Prices Senior Unsecured Notes Offering investment picks
BATON ROUGE, La., July 8, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc. (Nasdaq:AMED) , one of America's leading healthcare at home companies, announced today that it has been advised by the staff of the Securities and Exchange Commission ("SEC") that the investigation by the SEC related to the Company's operations and participation in the Medicare program has been completed and that the staff does not intend to recommend any enforcement action by the SEC.
Sign-up for Amedisys Announces Completion of SEC Investigation investment picks
MCLEAN, Va., July 8, 2014 (GLOBE NEWSWIRE) -- Iridium Communications Inc. (Nasdaq:IRDM) and its prime contractor, Thales Alenia Space, announced an important milestone in the development of the new Iridium NEXT constellation by completing the first successful end-to-end test call using Iridium NEXT hardware.
Sign-up for First Successful Call Completed Over Iridium Next Hardware investment picks
Eagle Pharmaceuticals Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) announced today that the United States Food and Drug Administration (“FDA”) has granted orphan drug designation to bendamustine hydrochloride (“HCl”), a ready-to-dilute concentrate solution for injection that will be administered by infusion over 10 minutes after dilution in 50mL of sodium chloride (“saline”) or a saline / dextrose mixture, for the treatment of chronic lymphocytic leukemia (“CLL”) and indolent B-cell non-Hodgkin’s lymphoma (“NHL”). Pursuant to the orphan drug designation, Eagle is eligible to receive tax incentives and Prescription Drug User Fee Act (“PDUFA”) fee savings, and believes it may receive seven years of marketing exclusivity.
Sign-up for Eagle Pharmaceuticals Receives Orphan Drug Designation for Lower Volume, Shorter Infusion Time Bendamustine Hydrochloride Product for Chronic Lymphocytic Leukemia and Indolent B-Cell Non-Hodgkin’s Lymphoma investment picks
Sign-up for Aben Announces Exploration Program at Mann Lake Uranium Project in the Athabasca Basin, Saskatchewan investment picks
BRIDGEVILLE, Pa., July 8, 2014 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq:USAP) announced today that Christopher M.
Sign-up for Universal Stainless Promotes Christopher Zimmer to Executive Vice President and Chief Commercial Officer investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that it will ring the Closing Bell at the NASDAQ MarketSite in Times Square, New York City, on Thursday, July 10, 2014, at 4:00 p.m. ET.
Sign-up for Verastem to Ring the NASDAQ Stock Market Closing Bell and Host Annual Research and Development Day on July 10, 2014 investment picks
Navigant (NYSE: NCI) announced today that it will report its financial results for the second quarter ended June 30, 2014 on Tuesday, July 29, 2014 before the market opens.
Sign-up for Navigant to Report Second Quarter 2014 Results on July 29, 2014 investment picks
Perion Codefuel, a division of Perion Network Ltd.
Sign-up for Perion Partners with CYREN to Enhance Browsing Safety for Its App Users investment picks
The Howard Hughes Corporation ® (NYSE: HHC) and Smith’s Food & Drug announced today plans for a 78,000 square-foot food and drug store in Holladay, UT.
Sign-up for The Howard Hughes Corporation® Announces Smith’s Food & Drug® as an Anchor for Cottonwood Redevelopment investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Actions Semiconductor Revises Revenue Outlook for the Second Quarter of 2014 to The Howard Hughes Corporation® Announces Smith’s Food & Drug® as an Anchor for Cottonwood Redevelopment
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices